Chromium and Sennosides drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Chromium (chromium) and Sennosides (senna). Common drug interactions include cerebral venous thrombosis among females and iron deficiency among males.

The phase IV clinical study analyzes what interactions people have when they take Chromium and Sennosides. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Chromium?

Chromium has active ingredients of chromium. It is often used in metabolism. eHealthMe is studying from 2,557 Chromium users. Check the latest studies of Chromium.

What is Sennosides?

Sennosides has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 8,247 Sennosides users. Check the latest studies of Sennosides.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

17 people who take Chromium and Sennosides together, and have interactions are studied.

Chromium and Sennosides drug interactions.

What are the common drug interactions of Chromium and Sennosides, by gender? *:

female:

Cerebral venous thrombosis (clot in brains venous blood system)
Headache (pain in head)
Neurological symptom (symptoms of nervous system disease)
Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Speech disorder
Thalamic infarction (tissue death of thalamus part of brain)
Migraine (headache)

male:

Iron deficiency
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Hepatic failure (liver failure)
Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Vomiting
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Skin ulcer
Abdominal discomfort

What are the common drug interactions of Chromium and Sennosides, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Skin ulcer
Abdominal discomfort
Alanine aminotransferase increased
Ascites (accumulation of fluid in the abdominal cavity)
Death
Gamma-glutamyltransferase increased
Hepatic failure (liver failure)
Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

50-59:

Cerebral venous thrombosis (clot in brains venous blood system)
Headache (pain in head)
Neurological symptom (symptoms of nervous system disease)

60+:

Migraine (headache)

What are the existing conditions these people have? *

Weight Loss: 6 people, 35.29%
Weight Decreased: 5 people, 29.41%
Birth Control: 3 people, 17.65%
Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 2 people, 11.76%
Stress And Anxiety: 2 people, 11.76%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 11.76%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 11.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
Dyspnea (difficult or laboured breathing): 2 people, 11.76%
Thyroid Diseases: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Chromium and Sennosides?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously